Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response—a prospective open-label study

被引：0

作者：

Naoki Hashimoto

Atsuhito Toyomaki

Minoru Honda

Satoru Miyano

Nobuyuki Nitta

Hiroyuki Sawayama

Yasufumi Sugawara

Keiichi Uemura

Noriko Tsukamoto

Tsukasa Koyama

Ichiro Kusumi

机构：

[1] Hokkaido University Graduate School of Medicine,Department of Psychiatry

[2] Child and Adolescent Psychiatry,Department of Psychiatry

[3] Department of Psychiatry University of California,undefined

[4] Honda Memorial Hospital,undefined

[5] Teine Hospital,undefined

[6] Sapporo Hanazono Hospital,undefined

[7] San-ai Hospital,undefined

[8] Psychiatric Medical Center,undefined

[9] Sapporo City General Hospital,undefined

[10] Hakodate Watanabe Hospital,undefined

[11] Oyachi Hospital,undefined

来源：

Annals of General Psychiatry | / 14卷

关键词：

Schizophrenia; Quetiapine; Switching; Antipsychotic; Negative symptom; Cognitive impairment; Treatment resistance;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Post-hoc analysis investigating the safety and efficacy of brexpiprazole in Japanese patients with schizophrenia who were switched from other antipsychotics in a long-term study (Secondary Publication)
Ishigooka, Jun
Usami, Tomohiro
Iwashita, Shuichi
Kojima, Yoshitsugu
Matsuo, Satoshi
NEUROPSYCHOPHARMACOLOGY REPORTS, 2020, 40 (02) : 122 - 129
[42] The Long-Term Efficacy and Safety of Flexibly-Dosed Adjunctive Intranasal Oxytocin in Patients with Schizophrenia; An Open-Label Study
Feifel, David
MacDonald, Kai
Cobb, Patrice
McKinney, Rebecca
Hadley, Allison
BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 320S - 320S
[43] Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study
Philipp, Thomas
Glazer, Robert D.
Zhao, Yanxing
Pospiech, Rainer
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (01) : 187 - 193
[44] Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis
Dellon, Evan S.
Collins, Margaret H.
Rothenberg, Marc E.
Assouline-Dayan, Yehudith
Evans, Larry
Gupta, Sandeep
Schoepfer, Alain
Straumann, Alex
Safroneeva, Ekaterina
Rodriguez, Cristian
Minton, Neil
Hua, Steven Y.
Hirano, Ikuo
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (03) : 473 - +
[45] An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
Gahan Pandina
Stuart Kushner
Keith Karcher
Magali Haas
Child and Adolescent Psychiatry and Mental Health, 6 (1)
[46] Long-Term Efficacy and Tolerability of Milnacipran in Fibromyalgia Patients: Results From A Three-Year, Open-Label, Flexible-Dosing Study
Arnold, Lesley M.
Ma, Yimin
Palmer, Robert H.
Spera, Allan
Baldecchi, Arlene
JOURNAL OF WOMENS HEALTH, 2012, 21 (04) : 18 - 19
[47] Long-Term Efficacy and Tolerability of Milnacipran: 3-Year Results from an Open-Label, Flexible-Dosing Study in Patients with Fibromyalgia
Arnold, Lesley
Spera, Allan
Baldecchi, Arlene
Trugman, Joel
Thacker, Kimberley
Wang, Yong
NEUROLOGY, 2012, 78
[48] Long-term treatment of chronic schizophrenia with risperidone: an open-label, multicenter study of 386 patients
Moller, HJ
Gagiano, CA
Addington, DE
Von Knorring, L
Torres-Plank, JF
Gaussares, C
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1998, 13 (03) : 99 - 106
[49] Long-term efficacy and tolerability of tacrolimus 0.03% ointment in infants:* a two-year open-label study
Mandelin, Johanna M.
Rubins, Andris
Remitz, Anita
Cirule, Kristine
Dickinson, James
Ho, Vincent
Makela, Mika J.
Rubins, Silvestrs
Reitamo, Sakari
Undre, Nasrullah
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2012, 51 (01) : 104 - 110
[50] Switching to quetiapine from other atypical antipsychotics improves sexual dysfunction: Preliminary results of an open-label study
Bouchard, RH
Demers, MF
Roy, MA
Almeras, N
Villeneuve, J
SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 180 - 180

← 1 2 3 4 5 →